MBD2 and cancer: For instance, in glioblastoma cells, the demethylases KDM6A/B, which target H3K27, are required for the maintenance of a subpopulation of quiescent cancer stem cells and their pharmacological inhibition with GSKJ4 selectively targets slow-cycling cancer stem cells [85].